Date(s) - 28/03/2019 - 29/03/2019
Location Address 1-13-11 Nanko-Kita, Suminoe-Ku, Osaka, Japan, 559-0034, Osaka
With the excellent accomplishment of Pharmacovigilance Series of Conferences in the UK, the USA in back to back a long time in the course of the most recent quite a while which met with extraordinary accomplishment in Business Conferencing.
It’s happy to report thirteenth Global Pharmacovigilance and Drug Safety Summit amid March 28-29, 2019 Osaka, Japan with the topic ‘’Promulgating the prevention of adverse drug reaction”. This is a 2-day Mega Event offering Exhibition, at the scene to grandstand the new and rising advancements with Keynote introduction, Oral, YRF (Student Presentation), blurb, e-publication Presentations.
We are happy to educate you that the Speaker/Delegate/Exhibitor openings are accessible at the meeting. kindly visit the website of the conference to find out about the scientific sessions and abstract submission, If needs to go to as Delegate, sympathetically enroll to the gathering. For any questions, mail us.
Our Confirmed Speakers:
Dr.Jacob Joseph, Harward Medical School, USA
Dr.Ujwala Salvi, Nucleon Therapeutics, India
Dr.Omer, Sanofi, Canada
Dr.Ashok, Clinfomatrix, USA
Mr.Chi Chen, E&Y, China
Dr.Meenal Patwardhan, Abbvie, USA
Mr.Rajiv Joshi, E&Y, India
Keynote (Day 2)
Dr.Essam, Celyad, Belgium
Dr.Carole, Sun Pharma, Japan
Mr.Robert, Accenture, Spain
Mr.Ravish Kumar, Salzman Group, Australia
Dr.Abdeen, Ministry of health, UK.
Dr.Ripal Gharia, Cliantha research, India
Mr.Mohammed Gayoor khan,NFPS,Malaysia
Salmanz Group, Australia
Nucleon Therapetics, India
Saudi Patient safety Center, Saudi
AlphaBeta Pharma, UK
King Abdullah Medical City (KAMC)
Please let me know your confirmation at the earliest convenience.
| Best Regards
Zoey A Williams| Program Coordinator
Global Pharmacovigilance 2019
Ph: 4896666555 Ext:6028